Literature DB >> 2650966

Pulmonary surfactant metabolism.

J R Wright1, S Hawgood.   

Abstract

Recent work suggests that surfactant undergoes a complex sequence of metabolic events during its life cycle in the alveolar airspace. The composition, turnover, and metabolism of surfactant, and the possible "control points" in its metabolic pathway that might be compromised in disease states are discussed.

Mesh：

Substances：

Year:  1989        PMID： 2650966

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN： 0272-5231            Impact factor:   2.878


  8 in total

Review 1.  Ventilation and secretion of pulmonary surfactant.

Authors:  H Wirtz; M Schmidt
Journal:  Clin Investig       Date:  1992-01

Review 2.  Respiratory diseases.

Authors:  D G James; O M Sharma
Journal:  Postgrad Med J       Date:  1990-01       Impact factor: 2.401

Review 3.  Recent progress on surfactant protein A: cellular function in lung and kidney disease development.

Authors:  Skylar D King; Shi-You Chen
Journal:  Am J Physiol Cell Physiol       Date:  2020-07-08       Impact factor: 4.249

4.  Fluidization of a dipalmitoyl phosphatidylcholine monolayer by fluorocarbon gases: potential use in lung surfactant therapy.

Authors:  Frédéric Gerber; Marie Pierre Krafft; Thierry F Vandamme; Michel Goldmann; Philippe Fontaine
Journal:  Biophys J       Date:  2006-02-24       Impact factor: 4.033

Review 5.  [Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome].

Authors:  S Lauer; L G Fischer; H D Stubbe; H Van Aken; M Westphal
Journal:  Anaesthesist       Date:  2006-04       Impact factor: 1.041

6.  Roles of three transporters, CbcXWV, BetT1, and BetT3, in Pseudomonas aeruginosa choline uptake for catabolism.

Authors:  Adel A Malek; Chiliang Chen; Matthew J Wargo; Gwyn A Beattie; Deborah A Hogan
Journal:  J Bacteriol       Date:  2011-04-08       Impact factor: 3.490

7.  Surfactant protein a promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus.

Authors:  J F Downing; R Pasula; J R Wright; H L Twigg; W J Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

8.  Piezo1 induced apoptosis of type II pneumocytes during ARDS.

Authors:  Guo-Peng Liang; Jing Xu; Li-Li Cao; Yi-Hua Zeng; Bai-Xu Chen; Jing Yang; Zhong-Wei Zhang; Yan Kang
Journal:  Respir Res       Date:  2019-06-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.